Scientists at the VIB–VUB Center for Structural Biology have uncovered a counterintuitive principle that could reshape how ...
In this interview, Dr. Fang-Yi Chu talks to NewsMedical about the role of transmembrane proteins in targeting oncology research. Can you explain what transmembrane proteins are and why they are ...
Effect of TT-816, a novel immune response modifier targeting cannabinoid CB2 receptor, on antitumor immunity and cancer growth. Antitumor mechanisms of OncoTherad (MRB-CFI-1) nanoimmunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results